Thursday, February 5, 2026
StockstToday.com Logo
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
StocksToday.com Logo
No Result
View All Result
Home Breaking News

Celsius Holdings Faces Stock Price Decline and Investor Confidence Challenge

Elaine Mendonca by Elaine Mendonca
January 19, 2024
in Breaking News
0
Beverages Industry Markets and money
0
SHARES
9
VIEWS
Share on FacebookShare on Twitter

On January 19, 2024, Celsius Holdings witnessed a significant decline in its stock price following a downgrade by B of A Securities. The renowned securities firm revised its rating from Buy to Neutral and set a price target of $65. As a result, the stock experienced an 11% drop during morning trading, settling at $53.30.

Despite the downward trend, it is worth noting that the analyst’s price target still indicates a considerable potential for growth. However, the decision to downgrade the stock has undoubtedly impacted its market value. B of A Securities made this call based on their assessment of various factors, including the company’s future prospects for expansion and potential growth in international markets.

Overall, the downgrade by B of A Securities has significantly impacted Celsius Holdings’ stock price on January 19, 2024. The company now faces the challenge of regaining investor confidence and demonstrating its ability to overcome the concerns raised by the analyst’s outlook.

Celsius Holdings Inc. Stock (CELH) Drops 10.54% on January 19, 2024: What Investors Need to Know

CELH, the stock of Celsius Holdings Inc., experienced a significant drop in its price on January 19, 2024. According to data sourced from CNN Money, the stock opened at $57.26, which was $2.34 lower than its previous closing price. The price drop of CELH shares on that day amounted to $6.28, representing a decline of 10.54%. Despite this decline, it is important to note that CELH is currently trading in the middle of its 52-week range. However, it is worth mentioning that trading in the middle of the range does not necessarily guarantee future stability. Additionally, the stock is trading above its 200-day simple moving average, indicating that the stock has been performing well in the long term. Investors should carefully consider these factors before making any decisions regarding CELH. It is crucial for investors to conduct thorough research, analyze market trends, and consult with financial advisors to gain a comprehensive understanding of CELH’s prospects and potential risks. Stock performance can be influenced by various factors, including company-specific news, industry trends, and overall market conditions. Investors should exercise caution and make informed decisions based on their individual investment goals and risk tolerance.

Celsius Holdings (CELH) Stock Performance on January 19, 2024: Analyzing Revenue, Net Income, and EPS

CELH Stock Performance on January 19, 2024: A Closer Look at the Numbers

On January 19, 2024, Celsius Holdings (CELH) stock experienced significant fluctuations in its performance. By analyzing the financial data sourced from CNN Money, we can gain insights into the company’s total revenue, net income, and earnings per share (EPS) for the past year and the third quarter.

Total Revenue:
CELH’s total revenue for the past year stood at $653.60 million, representing a remarkable 107.97% increase compared to the previous year. Furthermore, CELH’s total revenue for the third quarter amounted to $384.76 million, reflecting an 18.07% increase since the previous quarter.

Net Income:
CELH reported a loss of -$187.28 million over the past year. However, net income increased by 4856.64% since last year. In the third quarter, CELH’s net income rebounded strongly, reaching $83.95 million, reflecting a substantial 62.98% increase compared to the previous quarter.

Earnings per Share (EPS):
CELH reported an EPS of -$0.88 over the past year, representing a significant decrease of 5283.43% compared to the previous year. However, in the third quarter, CELH’s EPS rebounded strongly, reaching $0.30, reflecting a substantial 72.35% increase compared to the previous quarter.

Conclusion:
CELH’s stock performance on January 19, 2024, showcased remarkable growth in total revenue, net income, and EPS. Investors should closely monitor CELH’s financial performance, as the company demonstrates its potential for sustained growth and increased shareholder value.

Tags: CELH
Elaine Mendonca

Elaine Mendonca

Related Posts

NFT projects
Breaking News

The Impact of TikToks Fate on USChina Relations and American Tech Giants

March 16, 2024
Businesses finance
Breaking News

Blackstone Strategic Credit 2027 Term Fund BGB Announces Monthly Dividend of 93 Cents per Share

March 15, 2024
Healthcare-sector
Breaking News

Analyzing Short Interest in Molina Healthcare Inc MOH

March 15, 2024
Next Post

Processa Pharmaceuticals Inc Experiences Surge in Stock Price Due to Expansion of Next Generation Capecitabine in Breast Cancer Treatment

CTVA stock news

Lam Research Incs Unique PE Ratio and Considerations for Investment Decisions

Technology Robotics Stock Market Today

The Future of the Global IoT Market Projected Growth and Opportunities

Recommended

SKYX Platforms Stock

Marriott Partnership Signals Major Breakthrough for SKYX Platforms

5 months ago
Microsoft Stock

Microsoft’s AI Ambition: A High-Stakes Bet on Future Growth

18 hours ago
Turtle Beach Stock

Turtle Beach Forges PlayStation Alliance with New Gaming Headset

5 months ago
FLO stock news

Cemtrex Shares Surge After Halting Trading Due to Circuit Breaker

2 years ago

Categories

  • AI & Quantum Computing
  • Analysis
  • Analyst Ratings
  • Asian Markets
  • Automotive & E-Mobility
  • Banking & Insurance
  • Bitcoin
  • Blockchain
  • Bonds
  • Breaking News
  • Business & Industry Trends
  • Cannabis
  • Chemicals
  • Commodities
  • Consumer & Luxury
  • Crypto Stocks
  • Cryptocurrency
  • Cyber Security
  • DAX
  • Defense & Aerospace
  • Dividends
  • Dow Jones
  • E-Commerce
  • Earnings
  • Emerging Markets
  • Energy & Oil
  • ETF
  • Ethereum & Altcoins
  • European Markets
  • Forex
  • Gaming & Metaverse
  • Gold & Precious Metals
  • Healthcare
  • Hydrogen
  • Index
  • Industrial
  • Insider Trading
  • IPOs
  • Market Commentary
  • Market News
  • MDAX & SDAX
  • Mergers & Acquisitions
  • Nasdaq
  • Penny Stocks
  • Pharma & Biotech
  • Real Estate & REITs
  • Renewable Energy
  • S&P 500
  • Semiconductors
  • Space
  • Stock Picks
  • Stock Targets
  • Stocks
  • TecDAX
  • Tech & Software
  • Telecommunications
  • Trading & Momentum
  • Turnaround
  • Uncategorized
  • Value & Growth

Topics

Adobe Alibaba Alphabet Amazon AMD Apple ASML BioNTech Bitcoin Broadcom Coca-Cola Coinbase D-Wave Quantum Eli Lilly Fiserv IBM Intel Kraft Heinz Marvell Technology META Micron Microsoft MP Materials MSCI World ETF Newmont Mining NIO Novo Nordisk Nvidia Ocugen Opendoor Oracle Palantir PayPal Plug Power QuantumScape Robinhood Rocket Lab USA Strategy Super Micro Computer Synopsys Tesla Tilray Unitedhealth Uranium Energy Viking Therapeutics
No Result
View All Result

Highlights

CureVac Delisted Following BioNTech Acquisition Completion

Strategic Robotics Partnership Signals New Growth Phase for EOS Defence

NexPoint Residential Trust Sets Date for Annual and Q4 2025 Results

PC Connection Set to Report Full-Year and Fourth Quarter Earnings

Fossil Group Stock Surges Past Key Technical Threshold

NextGen Healthcare: Strategic Wins and Industry Accolades Signal Sustained Momentum

Trending

Rolls Royce Stock
Defense & Aerospace

Rolls-Royce Shares: A Pivotal Period for Growth and Diversification

by Dieter Jaworski
February 5, 2026
0

The coming weeks represent a critical juncture for Rolls-Royce. The company is poised to demonstrate whether it...

Viking Therapeutics Stock

Viking Therapeutics: Investors Await Key Clinical Updates in Forthcoming Report

February 5, 2026
Solana Stock

Solana Faces Billions in Potential Token Supply Releases

February 5, 2026
CureVac Stock

CureVac Delisted Following BioNTech Acquisition Completion

February 5, 2026
EOS Stock

Strategic Robotics Partnership Signals New Growth Phase for EOS Defence

February 5, 2026

StocksToday.com is your one-stop destination for the latest stock news and analysis. We provide in-depth coverage of the stock market, including market news, company news, sector news, IPO news, investment strategies, personal finance, international markets, and more.

Follow us on social media:

Recent News

  • Rolls-Royce Shares: A Pivotal Period for Growth and Diversification
  • Viking Therapeutics: Investors Await Key Clinical Updates in Forthcoming Report
  • Solana Faces Billions in Potential Token Supply Releases

Category

  • About
  • Advertise
  • Careers
  • Contact
  • Imprint
  • Privacy Policy
  • Terms of Service

© 2023 StocksToday.com

No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing

© 2023 StocksToday.com